Intra-Cellular Therapies (ITCI) Tops Q2 EPS by 11c

August 5, 2015 8:53 AM EDT
Get Alerts ITCI Hot Sheet
Price: $43.18 --0%

EPS Growth %: +11.0%

Today's EPS Names:
More
Trade Now! 
Join SI Premium – FREE

Intra-Cellular Therapies (NASDAQ: ITCI) reported Q2 EPS of ($0.61), $0.11 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $57.4 million versus the consensus estimate of $40 thousand.

For earnings history and earnings-related data on Intra-Cellular Therapies (ITCI) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

The Children's Investment Fund (TCI), Earnings